Search the Health & Medicine desk archive.
(MedPage Today) -- The FDA approved the small-molecule inhibitor pimicotinib (Pimjetmi) for selected patients with symptomatic tenosynovial giant cell tumor (TGCT) and high surgical risk. An oral selective inhibitor of colony stimulating factor...
Physician groups are seeking a delay for a new Medicare demonstration model. The model debuts January 1 and requires doctors treating low back pain and congestive heart failure to meet performance standards or face payment penalties. That means those physicians could see payment consequences tied to the standards if the model starts on schedule.
Hims & Hers struck a deal with Eli Lilly to offer the drugmaker’s branded obesity treatments through its online health and wellness platform.
Doximity is expanding its clinical AI footprint to more than 190 health systems. The company is also positioning clinical reliability as a competitive focus, launching DoseCheck and a partnership with Wolters Kluwer's UpToDate.
Brepocitinib produced dramatic improvement in patients with cutaneous sarcoidosis, a condition lacking any very effective therapy, in a small phase II trial presented in Orlando. The dual-acting TYK2/JAK1 inhibitor, marketed as Lisraya, was tested in a trial the excerpt describes only as small, without giving a patient count or effect size.
(MedPage Today) -- Reductions in hepatitis B surface antigen (HBsAg) were observed with a novel small interfering RNA (siRNA) therapy in patients with chronic hepatitis B virus (HBV) infection, according to a phase II study. Among patients randomized...
Researchers reported mixed results from a trial testing CAR T-cell therapy in rheumatoid arthritis. Data presented at a conference in Orlando suggested RA responds less consistently to the approach than lupus and certain other autoimmune conditions have.
Mayo Clinic Platform launched an AI-driven clinical decision support tool. Beginning in November, eligible clinicians will get a specialty-specific chat covering more than 35 specialties plus 22 clinical calculators available via chat or voice dictation.
A practical framework for assessing AI governance, evidence, transparency and post-deployment performance in clinical workflows.
Google Cloud released Gemini for healthcare, developed with clinical and health plan leaders. The company says the platform is built to support HIPAA compliance.
(MedPage Today) -- Results from the TroFuse-005 trial presented at the annual European Society for Medical Oncology congress showed that the investigational antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) significantly improved...
(MedPage Today) -- A sham-controlled trial showed that sleeping while using high‑efficiency particulate air (HEPA) filters in the bedroom improved blood sugar control, as highlighted by NYU Langone Health. A smartwatch artificial intelligence...
Three bladder cancer experts discussed emerging enfortumab vedotin-based treatment data at the ESMO congress in an exclusive roundtable. The discussion centered on muscle-invasive bladder cancer and the latest data presented at the meeting.
(MedPage Today) -- Results from the phase III PREVAIL trial presented at the American Association of Neuromuscular & Electrodiagnostic Medicine annual meeting showed that treatment with the investigational once-weekly nanobody gefurulimab significantly...
(MedPage Today) -- In patients treated with resmetirom (Rezdiffra), early responses in blood and imaging biomarkers were associated with resolution of metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis improvement, according to...
Nkarta will present initial clinical data for its natural killer cell therapy in two disorders, myositis and systemic sclerosis, during the American College of Rheumatology annual in Orlando this week. The biotech is part of a growing group of companies developing therapies that
Panelists at a recent digital health conference said patients increasingly expect convenient, consumer-focused healthcare experiences. They spoke at the MedCity INVEST Digital Health Conference.
When verification fails and an eligible member loses coverage, treatment can be interrupted, medications can go unfilled and manageable conditions can become medical emergencies. The post When Medicaid’s Data Can’t Verify Eligibility, Members Shouldn’t Lose Coverage appeared firs
To succeed, our healthcare system must fully embrace consumer-focused product design to address demands of scale, access, and daily usability that the market is revealing. The post When Patients Become Consumers: The New Care Stack Collides With Legacy Healthcare appeared first o
Women with breast cancer are abandoning an effective treatment because menopause symptoms go unowned by their care teams. No member of the care team is clearly responsible for managing those symptoms.
The weekly brief
One email a week with the stories that moved this field, plus what to watch next.
Fields marked * are required.